What predicts survival in glioblastoma? A population-based study of changes in clinical management and outcome

BACKGROUND: Glioblastoma is the most common and most aggressive primary brain tumor in adults. Despite multimodal treatment, the median survival time is 15–16 months and 5-year survival rate 5%–10%. The primary goal of this study was to identify prognostic factors for survival in an unselected popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekete, B., Werlenius, K., Tisell, M., Pivodic, A., Smits, A., Jakola, A. S., Rydenhag, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498299/
https://www.ncbi.nlm.nih.gov/pubmed/37711136
http://dx.doi.org/10.3389/fsurg.2023.1249366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498299/
https://www.ncbi.nlm.nih.gov/pubmed/37711136
http://dx.doi.org/10.3389/fsurg.2023.1249366

Ejemplares similares